Featured Research

from universities, journals, and other organizations

Screening effort turns up multiple potential anti-malaria compounds; Possible resistance-proof drug pairs found

Date:
August 5, 2011
Source:
NIH/National Institute of Allergy and Infectious Diseases
Summary:
Numerous potential anti-malarial candidate drugs have been uncovered by researchers. Researchers used robotic, ultra-high-throughput screening technology to test more than 2,800 chemical compounds for activity against 61 genetically diverse strains of lab-grown malaria parasites. They found 32 compounds that were highly effective at killing at least 45 of the 61 strains.

Numerous potential anti-malarial candidate drugs have been uncovered by investigators from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI), both parts of the National Institutes of Health (NIH).

Researchers at the NIH Chemical Genomics Center, administered by NHGRI, used robotic, ultra-high-throughput screening technology to test more than 2,800 chemical compounds for activity against 61 genetically diverse strains of lab-grown malaria parasites. They found 32 compounds that were highly effective at killing at least 45 of the 61 strains. Ten of these compounds had not previously been reported to have anti-malarial action, and seven were more active at lower concentrations than artemisinin, a widely used malaria drug. All the screened compounds are already registered as safe or approved for use in humans or animals, although not necessarily for use against malaria. The most promising compounds revealed in the new screen may thus face a shorter path than usual to development into anti-malarial drugs.

Scientists from NIAID's Laboratory of Malaria and Vector Research also determined that just three parasite genes -- the same three genes that confer resistance to currently used malaria drugs -- were associated with resistance to many of the screened compounds. This suggests that the malaria parasite has a limited number of ways to develop resistance following exposure to drugs. In theory, if drug combinations could be devised to target activity of all three resistance genes simultaneously, the parasite could be disarmed.

The research also provides a wealth of leads for scientists seeking to combine new or existing compounds into better multi-drug regimens against malaria. For example, the team identified dozens of compounds that act in a manner similar to artemisinin. Combining drugs that act similarly could yield treatment strategies that work better or require fewer doses.

Because malaria parasites can have a single genetic mutation that confers resistance to one drug while simultaneously increasing sensitivity to another drug, the investigators also looked for pairs of compounds with complementary activities. If used together, such complementary drug pairs could slow the emergence of drug resistance in parasites, because the parasite with the mutation -- which does not respond well to one compound -- would be killed by the other compound to which it has enhanced susceptibility conferred by the mutation. In this regard, the team found many compounds that killed strains of parasites resistant to a standard malaria drug, chloroquine. Since chloroquine-resistant parasites are widespread in many parts of the world, further studies of compounds with complementary activity could lead to new combination treatments for these drug-resistant parasites, the scientists write.

Co-authors Xin-zhuan Su, Ph.D., Chief, Malaria Functional Genomics Section, and Thomas E. Wellems, M.D., Ph.D., Chief, Laboratory of Malaria and Vector Research, NIAID, and Christopher Austin, M.D., Director, NIH Center for Translational Therapeutics, NHGRI, are available to comment.


Story Source:

The above story is based on materials provided by NIH/National Institute of Allergy and Infectious Diseases. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Yuan, K. C.-C. Cheng, R. L. Johnson, R. Huang, S. Pattaradilokrat, A. Liu, R. Guha, D. A. Fidock, J. Inglese, T. E. Wellems, C. P. Austin, X.-z. Su. Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets. Science, 2011; 333 (6043): 724 DOI: 10.1126/science.1205216

Cite This Page:

NIH/National Institute of Allergy and Infectious Diseases. "Screening effort turns up multiple potential anti-malaria compounds; Possible resistance-proof drug pairs found." ScienceDaily. ScienceDaily, 5 August 2011. <www.sciencedaily.com/releases/2011/08/110804141708.htm>.
NIH/National Institute of Allergy and Infectious Diseases. (2011, August 5). Screening effort turns up multiple potential anti-malaria compounds; Possible resistance-proof drug pairs found. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2011/08/110804141708.htm
NIH/National Institute of Allergy and Infectious Diseases. "Screening effort turns up multiple potential anti-malaria compounds; Possible resistance-proof drug pairs found." ScienceDaily. www.sciencedaily.com/releases/2011/08/110804141708.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins